89 results about "Implanted device" patented technology

A surgically implanted ocular optical array that can be used in both therapeutic and diagnostic applications is described. A device configured to be implanted in an eye includes: an imaging system that receives visible light incoming to the eye; optical source generating circuitry that generates an optical signal based on the light received by the imaging system; and an optical phased array (OPA) that generates and projects an image onto a retina of the eye in which the device is implanted, the image being based on the optical signal generated by the optical source generating circuitry.

An implant device for an eye disease to be inserted into an eyeball may include: a tube having one end to be inserted into an anterior chamber of the eyeball, the tube comprising a hollow portion through which aqueous humor is drained; and a ripcord inserted into the hollow portion of the tube to control an amount of aqueous humor drainage through the tube. In the implant device, an inner diameter of the tube and a diameter of the ripcord are determined so that pressure formed in the anterior chamber of the eyeball when the tube is inserted into the anterior chamber of the eyeball is within a preset pressure range. The pressure formed in an anterior chamber to an optimal range through an appropriate combination of the tube and the ripcord inserted into the tube.

The present invention provides a hair implantation device that can stably implant hair material onto a hair implantation net compared to conventional devices. [Solution] The hair implantation net comprises a net transport section, a hair material supply section, a hair implantation needle section, and a first restricting section that restricts the movement of the hair material. The hair implantation net has a first hole section and a second hole section adjacent to each other with a net thread in between. The hair implantation operation can be performed including an annular section forming operation in which the middle portion of the hair material is passed through the first hole section and the second hole section of the hair implantation net to form an annular section, and a hair material passing operation in which the hair implantation needle section is engaged with one end of the hair material beyond the annular section, and the hair material is moved so that the engaged portion of the hair material with the hair implantation needle section passes through the annular section. In the hair material passing operation, after the engaged portion has passed through the annular section, the movement of the portion between the engaged portion and the annular section is restricted by the first restricting section, and the hair implantation needle section is further moved to allow one end of the hair material to pass through the annular section.

An implantable device for sealing an aperture in a tissue of a body vessel, includes: an external fixation disposed on the outside of a vessel wall; a scaffold disposed on the inside of the vessel wall and interfacing with the external fixation, at least a portion of the scaffold disposed through an aperture in the vessel wall; and a patch disposed on the inside of the vessel wall and sandwiched between the external fixation and the scaffold, the patch substantially covering the full area of the aperture, thereby sealing the aperture.

The application provides a connector, an implantable electrode member using the connector, an electrode assembly, an implantable device and a preparation method thereof. The connector is used for connecting with an implantable electrode member and comprises an insulating body and a conductive terminal connected with the insulating body. The conductive terminal extends along a first direction and is connected with the insulating body, so that the electrode member can be connected with the conductive terminal in a vertical type along a second direction, and the first direction is different from the second direction. The connector, the implantable electrode member using the connector, the electrode assembly, the implantable device and the preparation method thereof can effectively improve circuit stability and prolong the service life of the electrode.

An insertion device configured to implant a first medical device and a second medical device in a user. The first medical device may be a fluid delivery cannula configured to deliver a fluid (e.g., insulin) to the user. The second medical device may be an analyte sensor (e.g., a glucose sensor) configured to detect a physiological characteristic of the user (e.g., a glucose level). The insertion device may be configured to be worn by the user. The insertion device includes a first linkage assembly configured to extend and retract a first insertion needle to implant the first medical device and a second linkage assembly configured to extend and retract a second insertion needle to implant the second medical device. The insertion device includes a user input device configured to cause the insertion device to initiate the implantation when activated by the user.

An implantable device comprising a fluid reservoir configured to hold fluid, an inflatable member configured to be implanted in a body of a patient, and an electronic pump assembly. The electronic pump assembly includes a controller configured to actuate at least one of a pump or an active valve to inflate the inflatable member, and a pressure sensor configured to monitor a pressure of the inflatable member. The controller is configured to detect a value of at least one at least one fluid transfer parameter for the pressure of the inflatable member to reach a target pressure during an inflation cycle. The controller is configured to generate size capability information of the inflatable member for the patient based on the detected value of the at least one fluid transfer parameter.

The present technology is directed to implantable medical systems that can include a first implantable device, a second implantable device, and a communication assembly that extends between and physically couples the first device and the second device. The first device can include one or more first electronic components, and the second device can include one or more second electronic components. The communication assembly can include (a) one or more first wires that are configured to wirelessly receive data from, and / or wirelessly transmit data to, a third device positioned external to the patient, and (b) one or more second wires that are configured to conductively transfer power between the first electronic components and the second electronic components. In some embodiments, the one or more first wires have a helical configuration, and the one or more second wires have a linear configuration and extend within the one or more first wires.

A method of sensing a physiological parameter involves advancing a delivery catheter to a right atrium of a heart of a patient via a transcatheter access path, advancing the delivery catheter through an atrial septal wall into a left atrium of the heart, deploying a distal anchor of a sensor implant device from the delivery catheter, anchoring the distal anchor of the sensor implant device to a first pulmonary vein, withdrawing the delivery catheter from the first pulmonary vein, thereby exposing at least a portion of a sensor module of the sensor implant device in the left atrium, deploying a proximal anchor of the sensor implant device from the delivery system, anchoring the proximal anchor of the sensor implant device to a second pulmonary vein, and withdrawing the delivery catheter from the heart.

The present disclosure relates generally to bioactive releasing membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the disclosure relates to novel bioactive releasing membranes, to devices and implantable devices including these membranes, methods for forming the bioactive releasing membranes on or around the implantable devices, and to methods for monitoring analyte levels in a biological fluid sample using an implantable analyte detection device.

Various embodiments of the present invention comprise a single-chamber collapsible and expandable prosthetic valve implant device with an elevated valve section and comprising the following capabilities: (1) preservation of native valve functionality; (2) initial preservation of native valve functionality with subsequent full replacement of native valve functionality; (3) full replacement of native valve functionality; and / or (4) mitigation of the prolapsing distance of the dysfunctional leaflets by preventing the anterior excursion of the prolapsing leaflets above the upper annular surface and into the left atrial chamber in order to preserve native leaflet functionality for as long as possible. The expanded and implanted device does not extend beyond the boundaries of the subject heart chamber, e.g., the left atrium, thereby enabling the preservation of any remaining native valve functionality with subsequent full replacement of native valve functionality if and when needed.

This invention provides a continuous implantation device for PDX model tumor tissue, comprising: a main cannula; and a pushing component disposed at one end of the main cannula. The continuous implantation device for PDX model tumor tissue provided by this invention utilizes the cooperation of structures such as the main cannula, the pushing component, the tissue sampler, and the retaining spring. The tissue sampler can be pre-loaded with multiple tumor tissue blocks, the retaining spring enables precise positioning and switching of the tissue sampler, the pushing component can sequentially push the tissue blocks for implantation, and the main cannula can be externally connected to an syringe to achieve simultaneous delivery of gel and tissue blocks. This device enables continuous implantation of tumor tissue blocks without the need for repeated clamping and transfer operations, significantly improving implantation efficiency and avoiding the decrease in activity caused by prolonged exposure of tissue blocks outside the body. Furthermore, it eliminates the need for clamping tissue blocks during transfer, reducing the risk of mechanical damage and ensuring the integrity of the tissue blocks. It also enables simultaneous delivery of tissue blocks, gel, and drugs, improving the experimental adaptability of the device.

A drill guide fixture may be configured to prepare a skull for attachment of a cranial insertion fixture. The drill guide fixture may include a central drill guide and a bone anchor guide at a base of the drill guide fixture. The central drill guide may define a central drill guide hole therethrough, wherein the central drill guide hole has a first opening at a base of the drill guide fixture and a second opening spaced apart from the base of the drill guide fixture. The bone anchor drill guide may define a bone anchor drill guide hole therethrough, and the bone anchor drill guide hole may be offset from the central drill guide hole in a direction that is perpendicular with respect to a direction of the central drill guide hole. Related cranial insertion fixtures, robotic systems, and methods are also discussed.

A system and method for defining at least one imaging region for assessing residual regurgitation. Medical imaging data of a heart having an implant device is obtained and processed to identify at least a position of the implant device. One or more locations of expected residual regurgitation are determined based at least one the identified position of the implant device and are used to define at least one imaging region for assessing residual regurgitation.

Systems, devices and methods are provided for supporting cardiac function. One system comprises an implantable intracardiac device comprising a motor and a pump, a transmitting resonator comprising a magnetic coil and configured to transmit a first level of power through an outer skin surface of the patient and a receiving resonator configured for implantation within the patient, comprising a magnetic coil and configured to transmit a second level of power to the motor within the implanted device. A controller is coupled to the transmitting resonator and configured to control the resonators and other parameters in the system such that the second level of power remains at or above a threshold level, thereby ensuring that the pump will continuously pump blood through the heart at a sufficient rate regardless of any changes in the system, such as power loss due to transmission inefficiencies and / or changes in the relative positions between the transmitting and receiving coils.

Disclosed are implantable devices, systems, and methods of fabricating, testing, optimizing, and / or implanting such devices. An implantable device includes a body, a first intrinsic channel network formed in the body and configured to receive cells, and a second intrinsic channel network formed in the body and configured to allow for active flow of a fluid to support viability and / or function of the cells in the first intrinsic channel network. The first intrinsic channel network comprises a first channel and the second intrinsic channel network comprises a second channel, with at least segments of the first and second channels parallel to and spaced apart from each other. Cells may be suspended in a collagen matrix and introduced to the first intrinsic channel network.

This disclosure relates to stimulation control. This document presents techniques for controlling stimulation provided by an implantable device. Stimulation control can be performed at an external device and can utilize machine learning (e.g., artificial intelligence (AI)). The techniques provide a cochlear implant stimulation strategy that utilizes computational models of the healthy hearing system and the implanted hearing system to more closely simulate natural acoustic hearing.

In some variations provided herein, the system for deep brain stimulation includes an implantable device that acquires and stores recordings of neural activity signals and applies electrical stimulation. The system also includes a personal controller device that establishes a first wireless connection to the implantable device. The personal controller device transmits power to the implantable device, and the implantable device transmits recordings of neural activity signals to the personal controller device via the first wireless connection. The system further includes a clinician programmer device that establishes a second wireless connection based on activation of the first wireless connection to receive recordings of neural activity signals from the implantable device. The clinician programmer device sets one or more stimulation parameters based on the neural activity signal recordings.

The present disclosure relates to valve replacement devices that are foldable for catheter-based deployment to the site of implantation, as well as systems for the delivery of valve prostheses, including prostheses having the special characteristics of the disclosed valve replacement devices. The devices include highly effective adhering mechanisms for secure and enduring precision implantation. The adhering mechanisms may employ a unique sealing mechanism that includes a cuff that expands slowly whereby the device is not secured in place until the completion of the implantation procedure. The implanted device, optionally together with the cuff, prevents perivalvular leaks and incorporate an appropriate leaflet system for reliable functioning in situ.

A stimulation system for a patient is provided. The system comprises: at least one implantable device comprising at least one implantable antenna; and an external device comprising at least one external antenna, wherein the at least one external antenna transfers power to the at least one implantable antenna. The at least one implantable device delivers therapy to the patient. A patient attachment device or body covering positions the at least one external antenna relative to the patient.

The present invention relates to a drug-eluting nanoengineered medical implant / contact device. The device comprises a nanocomposite and a drug, wherein the nanocomposite comprises hydrophilic polymer domains, hydrophobic polymer domains, water pores, and boundary charged double layers; wherein when the drug is hydrophilic, at least 80% of the drug partitions in the boundary charged double layers formed at the boundary interface of the hydrophilic polymer domains and water pores, and when the drug is hydrophobic, at least 80% of the dmg partitions in the boundary charged double layers formed at the boundary interface of the hydrophobic polymer domains and water pores. The device is configured to sustain the release of the drug at high precision and long duration.

The utility model relates to a spiral electrode implanting device, belong to medical instrument technology or the field of neuroscientific research, spiral electrode implanting device is located on the intracranial blood vessel wall, including a spiral support, electrode wire and developing object, the body of spiral support is a spiral shape, the electrode wire that is provided with on the support body is a spiral shape, the both ends of spiral support are equipped with developing object, the utility model can adopt the way of through blood vessel intervention, implants the electrode, gathers the electric signal, simple structure can realize high degree, electrode and blood vessel wall good adhesion, electrode gathers signal effect good, the cross section is small, can be transported through the small sheath, can reach the far end small blood vessel far end, satisfy brain deep position electrode collection and the electrode implanting requirement of intracranial multiple point (brain area).

The invention relates to self-assembled organosilane coatings for resorbable medical implant devices. The coatings can be prepared from coating compositions containing organosilane and can be applied to metal or metal alloy substrates. Prior to applying the coatings, the surfaces of the substrates can be pretreated. The coatings can be functionalized with a binding compound that is coupled with an active component. The coatings can be selectively removed, e.g., patterned, to expose portions of the uncoated substrate. Selecting different patterns can provide the ability to regulate or control various properties, such as, corrosion and hydrogen generation.

A method of managing security of an implanted device including estimating a risk to, or a need of, a user in who the device is implanted; and automatically applying, by the device, a security level regarding communication to the device and / or actions by the device according, to said estimation. In some mebdoimnts, the need is a medical need, such as an emergency situation. In some mebdoimnts the risk is assessed base don a location of the implanted device.

1. The name of the design product: sensor implant device. 2. The use of the design product: the product is a sensor implant device, which is suitable for implanting a biosensor into the subcutaneous tissue of a host. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: design 1 perspective view 1. 5. Design 1 is designated as the basic design. 6. Other circumstances that need to be explained: the components indicated by A and B in design 1 perspective view 1, the components indicated by C and D in design 2 perspective view 1, and the component indicated by E in design 3 perspective view 1 are all made of translucent material.

To provide an in-vivo device that can efficiently release drugs within the body. [Solution] An in-vivo implantation device 1 comprising a coil 10 having a lumen 11, and a linear stretch-resistant member 30 disposed in the lumen 11 and having fibers 31 containing a polymer material and a drug.

The utility model relates to detection equipment technical field, specifically disclose a kind of detection equipment of RFID chip implantation device, including conveyer belt, and the conveyer belt is installed horizontally by rack, and detection station is equipped on the conveyer belt;The detection mechanism includes the camera being installed just above detection station, and the light supplementing lamp being installed on the edge of detection station;The light supplementing lamp is located between camera and detection station, and several light supplementing lamps are installed on the edge above detection station;The utility model when RFID chip implantation device is driven by conveyer belt and enters detection station, is detected after switch response, make light supplementing lamp and camera start, adjust the irradiation angle of light supplementing lamp, i.